We examined insulin's effects on glucose transport and on subcellular transporter distribution in isolated human omental adipocytes of various sizes. Insulin stimulated 3-0-methylglucose transport by twofold in small cells, while a smaller and insignificant effect was measured in large cells. In the small cells, basal concentrations of glucose transporters were 2.9 and 17.2 pmol/mg membrane protein in the plasma and the low density microsomal membranes, respectively. Increasing cell size was associated with a 50% decrease in the concentration of transporters in each fraction, with no change in their total number per cell. Insulin stimulated the translocation of transporters from the intracellular pool to the plasma membranes, irrespective of cell size. Thus, insulin resistance at the postreceptor level, observed in human obesity, may be associated with a relative depletion of total transporters per cell together with a reduction in their intrinsic activity at the plasma membrane level.
Introduction
A fundamental action of insulin in promoting glucose metabolism in adipose and muscle cells is its stimulation of glucose transport. Recent studies in rat adipocytes by Wardzala et al.
(1), Cushman and Wardzala (2), Karnieli et al. (3) , and independent studies by Kono and coworkers (4) (5) (6) (7) , have established that insulin stimulates glucose transport in the isolated rat adipose cell through a rapid, reversible, and hormone concentrationand energy-dependent translocation of glucose transporters from a large intracellular pool to the plasma membrane. Horuk et al. (8) have provided evidence for a similar translocation mechanism in isolated guinea pig adipose cells, and Wardzala and Jeanrenaud (9, 10) have suggested the existence of such a mechanism in the rat diaphragm. However, a similar mechanism of insulin action has not yet been demonstrated in human adipose cells.
The clinical significance of this novel concept of insulin action has emerged from three experimental models of insulin resistance: (a) the streptozotocin-diabetic rat (1 1), (b) the high fat/low carbohydrate-fed rat ( 12) , and (c) the aged, obese male rat (13) . In each ofthese experimental models, the marked postreceptor insulin resistance of the adipose cell is associated with a relative depletion ofthe intracellular pool, from which glucose transporters are translocated to the plasma membrane in response to insulin.
The present studies were undertaken in order to demonstrate that insulin stimulates glucose transport in human omental adipose cells through the same translocation process as previously shown in the rat, and to examine glucose transporter distribution in human obesity.
Methods
Patients and adipose tissue. Human omental adipose tissue was obtained from Caucasian patients, none ofwhom were known to have any thyroid, renal, or adrenal abnormalities. The patients were undergoing an elective abdominal surgery. Patients followed a weight maintenance diet for 3 d before the operation. After an overnight fast, general anesthesia was induced with a short-acting barbiturate and maintained with a mixture of halothane, nitrous oxide, and oxygen. For each experiment, -50-100 g of omental tissue were removed from each patient as soon as possible after the operation began. After removal from the patient, the adipose tissue samples were kept in normal saline containing 5 mM glucose at 370C during the 5-min period required for their transport to the laboratory. All procedures were approved by the Rambam Medical Center and the Technion Institute Human Rights Boards, and informed written consent was obtained from each patient.
Adipose cells and subcellular membrane fractions. Isolated adipose cells were prepared according to the method described by Rodbell (14) and modified by Pederson et al. (15) , using 3 mg/ml collagenase. All incubations were carried out in Krebs-Ringer bicarbonate/Hepes buffer (standard Krebs-Ringer bicarbonate buffer reduced to 10 mM HCO3 and supplemented with 30 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), pH 7.4, containing 4% crude bovine serum albumin (Fraction V). In each experiment, at least 50 g of omental adipose tissue from each patient were needed in order to acquire 30 ml of 40% cell suspension, which yielded enough membranes for two preparations (basal and insulin-stimulated). In each experiment, cells from one patient were collected and pooled together. Adipose cell size was measured using a cell-counting chamber and eyepiece micrometer, assuming that the cells had spherical shape. The mean cell size was used for further calculations. Small cells were collected from six normal patients (percent ofideal body weight [%IBW]' < 120) while large cells were collected from four obese ones (%IBW > 120). After isolation, the pooled adipose cells from each patient were equally distributed in 15-ml volumes to two 950-ml polypropylene jars (basal and insulin-stimulated preparations, respectively), each containing 21 ml ofincubation medium. The cells were preincubated for 15 min at 370C, then insulin was added to a final concentration of 0 or 7.0 nM (1,000 AU/ml) and incubations were continued for another 30-45 min. 70-til replicate samples were then removed from either preparation to determine the basal and the insulin-stimulated rates of 3-0-methylglucose transport, according to the method described by Whitesell and Gliemann (16) and modified by Pederson and Gliemann (17), using 0.1 mM of 3-O-methylglucose as a substrate. In each experiment (namely, for each patient), plasma and low density microsomal membrane fractions were prepared from the incubated cells (basal or insulin-stimulated) by the differential ultracentrifugation method described elsewhere (2, 3, 18) , and modified as follows. Briefly, incubated cells were washed twice by centrifugation at 1,000 gfor 2 min, and homogenized at 17'C in a buffer containing 20 mM Tris-HCl, I mM EDTA, and 255 mM sucrose, pH 7.4. All steps after homogenization were carried out at 4VC using this buffer. Each homogenate, from basal and insulin-stimulated preparations, was then centrifuged at 16,000 g for 15 min. The supernatant was aspirated and saved, and the fat cake discarded. The pellet (containing plasma membranes, mitochondria, and nuclei) was wahsed once, repelleted at 17,000 g for 20 min, resuspended in 4.5 ml of buffer, then layered on top of a 1. 12-M sucrose cushion containing 20 mM Tris-HCI and I mM EDTA, pH 7.4, and centrifuged at 101,000 gfor 65 min. The plasma membrane band was washed twice by centrifugation at 200,000 g and resuspended to a final concentration of 1-2 mg protein/ml. The lowdensity microsomal membrane fraction was obtained from the initial 16,000 g supernatant, first by centrifugation at 48,000 g for 15 min, yielding a pellet of high density microsomal membranes,2 and then by recentrifugation of the 48,000 g supernatant at 360,000 g for 60 min. The latter pellet, the low density microsomal membrane fraction, was washed once and resuspended to a final concentration of 1-2 mg protein/ml.
Equilibrium D-glucose-inhibitable cytochalasin B binding to the plasma and low density microsomal membrane fractions was then measured in the presence of 4.63 uM cytochalasin E and the concentration of the D-glucose-inhibitable binding sites calculated by a modification of the method previously described (1, 2 (2) by an IBM personal computer using a CBCAL (APL System, Micosys Ltd., Haifa, Israel) program. This method is ofparticular advantage in estimating low concentrations of transporters, as found in human adipose cells.
As the Scatchard plots obtained in presence of D-glucose only approached a straight line, this number of cytochalasin B binding sites is only an estimation of the number of glucose transporters.
The reproducibility of the fractionation procedure between experimental points and among experiments was assessed by measuring the specific marker enzyme activities of 5' nucleotidase, rothenone-insensitive NADH-cytochrome C reductase, and UDP-galactose:N-acetylglucosamine galactosyl transferase in each fraction and in the original homogenate (19) (20) (21) (Fig. 1 A) , or per cellular surface area (Fig. 1 B) . With either method ofcalculation, insulin significantly stimulated glucose transport by twofold (P < 0.05) in cells isolated from normal patients. A smaller and statistically insignificant increase oftransport rate was measured in obesity. When calculated per cell (Fig. 1 A) rate of glucose transport in the normal group did not differ significantly from that ofthe obese one (P> 0.05). However, when calculated per cellular surface area, a 30% decrease in the basal transport rate could be noted in obesity (Fig. 1 B) .
Glucose transporter distribution in relation to cell size. In each group of patients (based upon cell size), insulin enhanced the concentration of transporters in the plasma membranes by 30-50%, as compared with the basal state (Fig. 2 A) . In the basal state, the concentration ofglucose transporters in the low density microsomes of each patient examined (Fig. 2 B) , was six to sevenfold higher than that observed in the plasma membranes (P < 0.05). Insulin decreased the concentration ofthese transporters by about 20-30%. In the human omental adipose cell, an increase in cell size was accompanied by a decrease in concentration of glucose transporters either in basal or in insulin-stimulated states, in both membrane fractions examined.
Glucose transporter distribution in normal versus obese patients. Glucose transporter concentration was measured in subcellular membrane fractions prepared from basal and insulinstimulated adipose cells. For each group of patients, the individual values for every fraction examined were averaged, and the mean concentrations of glucose transporters were compared, as shown in Fig. 3 ranes prepared from adipose cells isolated from normal In the plasma membranes (Fig. 3 A) ualitatively, the same concentration relationship also holds
In the basal state, concentration of glucose transporters in e transporters in membrane fractions prepared from adithe low density microsomes (Fig. 3 B) was about sixfold higher es of obese patients. However, in the latter, insulin exerted both in normal and in obese patients than that observed in the ller effect (insignificant at the P < 0.05 level) both in inplasma membranes of the same patients, respectively. Furtherng the level oftransporters in the plasma membranes, from more, concentration of glucose transporters in the intracellular ).2 to 2.0±0.3 pmol/mg membrane protein, and in depool was significantly higher in normals, compared with obese Lng it in the low density microsomes, from 9.1±1. 4 icant at the P < 0.05 level).
Total recoveries of specific marker enzyme activities among Cell Diameter (prn) the different membrane fractions are shown in Table III , and e 2. Relationship between cell size and glucose transporter coninclude 5'-nucleotidase, rothenone-insensitive NADH-cytotion in subcellular membrane fractions of human adipose cells. chrome C reductase, and UDP-galactose:N-acetylglucosamine cytes, were isolated from omental adipose tissue obtained from galactosyltransferase, which characterize the plasma membranes, rmal (e, o) and four obese (A A) patients. For each patient, the the endoplasmic reticulum, and the Golgi apparatus, respectively vere preincubated with (e, A, 
Discussion
The present data add support to the hypothesis that insulin stimulates glucose transport in the intact human adipose cell by a mechanism similar to that postulated for isolated rat and guinea pig adipose cells and rat diaphragm, namely, through the translocation of glucose transporters from a large intracellular pool to the plasma membrane. The subcellular fractionation procedure used here for human adipose cells seems to be analogous to that described for the rat adipocyte. In the human omental adipose cell, basal and insulinstimulated concentrations of glucose transporters are shown to decrease with increasing cell size. Furthermore, insulin's effect in stimulating the translocation of transporters is preserved in all cell sizes, even in the largest cell measured.
Our results are consistent with those of Hissin et al. (13) on The fact that only an estimated number of transporters can be reached while using the cytochalasin B binding assay raises the question of expression of transporters present in the plasma membrane. As glucose transport activity depends not only on the number of transporters but also on their intrinsic activity, changes in the processes of insertion/fusion with the plasma membrane and/or the fluidity of the plasma membrane may be associated with enlargement of the cell and could thus lead to a discrepancy between the magnitude of insulin's translocating effect and the resultant enhancement of glucose transport.
The latter possibility gains further support from works done by us (25) , by Kahn and Cushman (26) in insulin-treated diabetic rats, and by Smith et al. (27) , which evaluate the effect of adenosine on glucose transport activity and glucose transporters in rat adipose cells. We have shown a large discrepancy between the glucose transport activity in either basal or insulin-stimulated states in the intact cell and the concentration of transporters after 8-d insulin therapy. After 14-d insulin therapy, this discrepancy partially disappeared (25) . In all of the above cases, in the presence of a low concentration of transporters in the plasma membranes, glucose transport was increased disproportionately.
Thus, the discrepancy we found between the number of transporters and glucose uptake rate may be due to the presence of a regulator for glucose transport that may, at least in part, act by modulating the intrinsic activity of the transporter. Such a regulator can exist in different amounts in various pathophysiological states, and may be almost absent in obesity. Further studies are needed to elucidate this hypothetical mechanism.
The down-regulation ofglucose transporters found in plasma membrane in basal and insulin-stimulated states may represent a negative feedback mechanism regulating the rate of cellular growth in such a way that, as the cell enlarges, glucose uptake is correspondingly reduced and further growth is thus controlled. The various factors regulating the intracellular pool of transporters are as yet not clearly understood. The size of the pool of transporters can be regulated by insulin itself, can be genetically determined, or can depend on differences in sex and species (28, 29) .
